---
title: "ALVO.US (ALVO.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ALVO.US/news.md"
symbol: "ALVO.US"
name: "ALVO.US"
parent: "https://longbridge.com/zh-CN/quote/ALVO.US.md"
datetime: "2026-03-14T10:22:48.493Z"
locales:
  - [en](https://longbridge.com/en/quote/ALVO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALVO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALVO.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/ALVO.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ALVO.US/news.md)


# ALVO.US (ALVO.US) — 相关新闻

### [Alvotech (ALVO) Projected to Post Earnings on Wednesday](https://longbridge.com/zh-CN/news/278672668.md)
*2026-03-11T07:12:56.000Z*
> Alvotech (NASDAQ: ALVO) is set to release its Q4 2025 earnings on March 18, with analysts expecting earnings of $0.13 pe

### [Alvotech, a global biotech company, will announce Q4 and full year 2025 results on March 18, 2026 after US markets close.](https://longbridge.com/zh-CN/news/277745911.md)
*2026-03-04T08:01:58.000Z*
> On March 4, 2026, in Reykjavik, Iceland, the biotechnology company Alvotech (NASDAQ: ALVO) shared its plan to unveil the

### [Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results | ALVO Stock News](https://longbridge.com/zh-CN/news/277744411.md)
*2026-03-04T00:00:00.000Z*
> Alvotech (NASDAQ: ALVO) will release its fourth quarter and full year 2025 financial results on March 18, 2026, after U.

### [Alvotech (NASDAQ:ALVO) Given Average Recommendation of "Reduce" by Analysts](https://longbridge.com/zh-CN/news/277432815.md)
*2026-03-02T08:53:29.000Z*
> Alvotech (NASDAQ:ALVO) has received an average rating of "Reduce" from six analysts, with three recommending a sell, one

### [Is There Now an Opportunity in Alvotech (ALVO) After a 64% One-Year Share Price Slide?](https://longbridge.com/zh-CN/news/276074198.md)
*2026-02-16T18:48:11.000Z*
> Alvotech's stock has seen a significant decline of 64.3% over the past year, currently priced at US$4.64. Despite recent

### [Assessing Alvotech (ALVO) Valuation After AVT80 Trial Success And New Sandoz Agreements](https://longbridge.com/zh-CN/news/275655668.md)
*2026-02-11T20:57:37.000Z*
> Alvotech (ALVO) shares gained attention after positive results for its AVT80 biosimilar candidate and new agreements wit

### [Alvotech Announces Increase in Number of Own Shares | ALVO Stock News](https://longbridge.com/zh-CN/news/275634458.md)
*2026-02-11T08:00:00.000Z*
> Alvotech has increased its share capital by USD 125,000 through the issuance of 12.5 million ordinary shares, all subscr

### [03:02 ETRosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO](https://longbridge.com/zh-CN/news/275283012.md)
*2026-02-09T08:03:57.000Z*
> Rosen Law Firm is investigating potential securities claims for Alvotech (NASDAQ: ALVO) shareholders due to allegations 

### [Alvotech (NASDAQ:ALVO) Given Consensus Recommendation of "Hold" by Brokerages](https://longbridge.com/zh-CN/news/274952908.md)
*2026-02-05T10:13:30.000Z*
> Alvotech (NASDAQ:ALVO) has received an average recommendation of "Hold" from six research firms. Two analysts rated it a